Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
74,000
+5,000 (7.25%)
Sep 9, 2026, 3:30 PM KST

Mezzion Pharma Revenue

Mezzion Pharma had revenue of 2.20B KRW in the quarter ending June 30, 2026, with 26.18% growth. This brings the company's revenue in the last twelve months to 8.43B, up 6.92% year-over-year. In the year 2025, Mezzion Pharma had annual revenue of 7.91B, down -8.15%.

Revenue (ttm)
8.43B
Revenue Growth
+6.92%
P/S Ratio
268.71
Revenue / Employee
468.25M
Employees
18
Market Cap
2.26T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.91B-702.12M-8.15%
Dec 31, 20248.61B-23.11B-72.85%
Dec 31, 202331.72B994.76M3.24%
Dec 31, 202230.73B4.07B15.28%
Dec 31, 202126.65B-1.98B-6.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
DongKook Pharmaceutical979.60B
Huons Global846.78B
PharmaResearch603.58B
ST Pharm386.46B
Sam Chun Dang Pharm.259.90B
BINEX157.28B
Oscotec144.18B
CG Invites30.11B
Revenue Rankings